Document:

Exhibit 10.101

 

LIMITED WAIVER TO NOTE WARRANT AND
PURCHASE AGREEMENT

 

This LIMITED WAIVER
TO NOTE WARRANT AND PURCHASE AGREEMENT (this “Agreement”), dated as of October 2, 2015, is made by and between
TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation (“Parent”), TWINLAB CONSOLIDATION CORPORATION, a Delaware
corporation (“TCC”), TWINLAB HOLDINGS, INC., a Michigan corporation (“Twinlab Holdings”),
ISI BRANDS INC., a Michigan corporation (“ISI Brands”), and TWINLAB CORPORATION, a Delaware corporation (“Twinlab
Corporation”), NUTRASCIENCE LABS, INC., a Delaware corporation, NUTRASCIENCE LABS IP CORPORATION., a Delaware corporation
(each of the foregoing Persons being referred to herein individually as a “Company” and collectively as the
“Companies”), and JL-MEZZ UTAH, LLC, an Alaska limited liability company, f/k/a JL-BBNC Mezz Utah, LLC (the
“Purchaser”).

 

WHEREAS, the Companies
and the Purchaser are parties to a Note and Warrant Purchase Agreement dated as of January 22, 2015 (as amended, restated, amended
and restated, supplemented or otherwise modified from time to time, the “Note Purchase Agreement”);

 

WHEREAS, on the date
hereof the Companies will purchase all of the outstanding equity interests of Target 1 and such acquisition is a Permitted Acquisition
under the Purchase Agreement so long as no Default of Event of Default shall have occurred or would result from the consummation
of the Target 1 Acquisition; and

 

NOW, THEREFORE, in
consideration of the promises and the mutual agreements contained in this Agreement, and subject to the terms and conditions set
forth herein, each party hereto hereby agrees as follows:

 

1.          Capitalized
Terms. Capitalized terms used but not defined herein shall have the meanings set forth in the Note Purchase Agreement.

 

2.          Joinder
of New Subsidiaries. At the request of and as an accommodation to the Companies and subject to the strict compliance with the
terms, conditions and requirements set forth herein (including, without limitation, satisfaction of each of the conditions set
forth in Section 6 below), the Purchaser hereby agrees to allow 30 days from the date hereof for Organic Holdings LLC and its Subsidiaries
to join the Note Purchase Agreement as Companies, grant Liens in substantially all of their assets to secure the Obligations and
otherwise comply with Section 5.4 of the Note Purchase Agreement.

 

3.          Limited
Waiver to Note Purchase Agreement. At the request of and as an accommodation to the Companies and subject to the strict compliance
with the terms, conditions and requirements set forth herein (including, without limitation, satisfaction of each of the conditions
set forth in Section 6 below), the Purchaser hereby agrees to waive the Event of Default set forth on Schedule A attached
hereto (the “Specified Event of Default”). The limited waiver set forth in this Section 3 is effective solely
for the purposes set forth herein and shall be limited precisely as written and shall not be deemed to (a) except as expressly
provided herein, be a consent to any amendment, waiver or modification of any term or condition of the Note Purchase Agreement
or of any other Transaction Document; (b) prejudice any right that the Purchaser have or may have in the future under or in connection
with the Note Purchase Agreement or any other Transaction Document; (c) waive any Event of Default (other than the Specified Event
of Default) that exists as of the date hereof; or (d) establish a custom or course of dealing among any of the Companies, on the
one hand, or the Purchaser on the other hand.

 

    	1

     

    

 

4.          Representations
and Warranties; No Default. Each Company hereby represents and warrants that:

 

4.1.       The
execution, delivery and performance by such Company of this Agreement (a) are within such Company’s corporate or similar
powers and, at the time of execution hereof and have been duly authorized by all necessary corporate and similar action; (b) does
not and will not result, in any breach or default under any other document, instrument or agreement to which a Company or any of
its Subsidiaries is a party or to which a Company or any of its Subsidiaries, the Premises, the Collateral or any of the property
of a Company or any of its Subsidiaries is subject or bound, except for such breaches or defaults which, individually or in the
aggregate, have not had, and would not reasonably be expected to result in, a Material Adverse Effect and (c) will not violate
any applicable law, statute, regulation, rule, ordinance, code, rule or order.

 

4.2.       This
Agreement has been duly executed and delivered for the benefit of or on behalf of each Company and constitutes a legal, valid and
binding obligation of each Company, enforceable against such Company in accordance with its terms except (a) as the same may be
limited by bankruptcy, insolvency, reorganization moratorium or similar laws now or hereafter in effect relating to creditors rights
generally and (b) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to
equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

 

4.3.       Both
before and after giving effect to this Agreement on the date hereof (a) the representations and warranties of the Companies contained
in Section 4.1 of the Note Purchase Agreement and the other Transaction Documents are true, correct and complete on and as of the
date hereof as if made on such date (and to the extent any representations and warranties shall relate to the Effective Date or
another earlier date, such representation and warranties shall be deemed to be amended to relate to the date hereof), and (b) except
as set forth on Schedule A attached hereto, no Default or Event of Default has occurred and is continuing.

 

4.4.       The
acquisition of all of the equity interests of Organic Holdings LLC and its Subsidiaries is a Permitted Acquisition.

 

5.          Ratification
and Confirmation. The Companies hereby ratify and confirm all of the terms and provisions of the Note Purchase Agreement and
the other Transaction Documents and agree that all of such terms and provisions, as amended hereby, remain in full force and effect,
except as, and to the extent expressly set forth herein.

 

6.          Condition
to Effectiveness. The effectiveness of this Agreement shall be subject to the satisfaction of the following conditions precedent:

 

6.1.       The
Purchaser shall have received a fully executed copy of this Agreement.

 

6.2.       All
representations and warranties of the Companies contained herein shall be true and correct in all material respects as of the date
hereof (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof).

 

6.3.       The
Purchaser shall have received all fees and other amounts due and payable to the Purchaser and its counsel in connection with this
Agreement, and to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid
by the Companies under the Note Purchase Agreement.

 

    	2

     

    

 

7.          Miscellaneous.

 

7.1.       Except
as otherwise expressly set forth herein, nothing herein shall be deemed to constitute an amendment, modification or waiver of any
of the provisions of the Note Purchase Agreement, the Security Agreement or the other Transaction Documents, all of which remain
in full force and effect as of the date hereof and are hereby ratified and confirmed. Each Company hereby acknowledges and agrees
that nothing contained herein shall be deemed to entitle any Company to consent to, or a waiver, amendment or modification of,
any of the terms, conditions, obligations, covenants or agreements contained in the Transaction Documents in similar or different
circumstances. This Agreement (together with any other document executed in connection herewith) is not intended to be, nor shall
it be construed as, a novation of the Note Purchase Agreement.

 

7.2.       This
Agreement may be executed in any number of counterparts, each of which, when executed and delivered, shall be an original, but
all counterparts shall together constitute one instrument. Delivery of an executed counterpart of a signature page of this Agreement
by facsimile or electronic mail shall be equally effective as delivery of a manually executed counterpart of this Agreement.

 

7.3.       This
Agreement shall be governed by the laws of the State of New York without giving effect to any conflict of law principles and shall
be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 

7.4.       The
Companies agree to pay all reasonable expenses, including legal fees and disbursements, incurred by Purchaser in connection with
this Agreement and the transactions contemplated hereby.

 

7.5.       This
Agreement shall be deemed a Transaction Document for all purposes of the Note Purchase Agreement and the other Transaction Documents.
On and after the date hereof, each reference in the Note Purchase Agreement and the other Transaction Documents to the Note Purchase
Agreement, shall mean and be a reference to the Note Purchase Agreement, as modified by this Agreement.

 

7.6.       Each
Company, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself
and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each
of their respective current and former directors, officers, shareholders, agents, and employees (collectively, “Releasing
Parties”), does hereby fully and completely release, acquit and forever discharge each Indemnified Party of and from
any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands
of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate
or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Indemnified Parties (or any of them)
that directly or indirectly arise out of, are based upon or are in any manner connected with any Prior Related Event. “Prior
Related Event” means any transaction, event, circumstance, action, failure to act, occurrence of any type or sort, whether
known or unknown, which occurred, existed, was taken, was permitted or begun in accordance with, pursuant to or by virtue of (a) any
of the terms of this Agreement or any other Transaction Document, (b) any actions, transactions, matters or circumstances
related hereto or thereto, (c) the conduct of the relationship between the Purchaser and any Company, or (d) any other
actions or inactions by the Purchaser, all on or prior to the date hereof. Each Company acknowledges that the foregoing release
is a material inducement to the Purchaser’s decision to enter into this Agreement and to agree to the modifications contemplated
hereunder.

 

    	3

     

    

 

[Signature Pages Follow.]

 

    	4

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement which shall be deemed to be a sealed instrument as of the date first above written.

 

	 	COMPANIES
	 	 
	 	TWINLAB CONSOLIDATED HOLDINGS, INC.
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	  Thomas A. Tolworthy
	 	Title:	  Chief Executive Officer and President
	 	 
	 	TWINLAB HOLDINGS, INC.
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	  Thomas A. Tolworthy
	 	Title:	  Chief Executive Officer and President
	 	 
	 	TWINLAB CONSOLIDATION CORPORATION
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	  Thomas A. Tolworthy
	 	Title:	  Chief Executive Officer and President
	 	 
	 	TWINLAB CORPORATION
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	  Thomas A. Tolworthy
	 	Title:	  Chief Executive Officer and President
	 	 
	 	ISI BRANDS, INC.
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	  Thomas A. Tolworthy
	 	Title:	  Chief Executive Officer and President

 

[Signature Page – Limited Waiver
to Note and Warrant Purchase Agreement]

 

     

     

    

 

	 	NUTRASCIENCE LABS, INC.
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	  Thomas A. Tolworthy
	 	Title:	  Chief Executive Officer and President
	 	 
	 	NUTRASCIENCE LABS IP CORPORATION
	 	 
	 	By:	/s/ Thomas A. Tolworthy
	 	Name:	  Thomas A. Tolworthy
	 	Title:	  Chief Executive Officer and President

 

[Signature Page – Limited Waiver
to Note and Warrant Purchase Agreement]

 

     

     

    

 

	 	JL-MEZZ UTAH, LLC
	 	a Alaska Limited Liability Company
	 	 
	 	By:	/s/ Joshua D. Hodes
	 	Name:	  Joshua D. Hodes
	 	Title:	  Authorized Representative

 

[Signature Page – Limited Waiver
to Note and Warrant Purchase Agreement]

 

     

     

    

 

Schedule A

 

Events of Default

 

The Company failed to meet its Minimum
Adjusted EBITDA covenant for July 2015 and August 2015. These defaults create cross defaults within these agreements and the Company’s
credit facility with MidCap.Exhibit 10.102

 

AMENDMENT NO. 1 TO

AGREEMENT FOR LIMITED WAIVER OF NON-CIRCUMVENTION
PROVISION AND TO COMPROMISE AGREEMENT AND RELEASE

 

THIS AMENDMENT NO.
1 TO AGREEMENT FOR LIMITED WAIVER OF NON-CIRCUMVENTION PROVISION AND TO COMPROMISE AGREEMENT AND RELEASE (the “Amendment”)
is made as of this 1st day of October, 2015, by and between Twinlab Consolidated Holdings, Inc., a Nevada corporation
(the “Company”), and Capstone Financial Group, Inc., a Nevada corporation (“Capstone”).

 

WHEREAS, the
Company and Capstone are parties to that certain Agreement for Limited Waiver of Non-Circumvention Provision, dated as of July
5, 2015 (the “Waiver Agreement”), whereby Capstone, for a fee as set forth therein, agreed to provide the Company
with a limited waiver of the “Noncircumvention Provision” (as defined in the Waiver Agreement) with respect to a particular
“Investor” (as defined in the Waiver Agreement);

 

WHEREAS, the
Company and Capstone are also parties to that certain Compromise Agreement and Release, dated as of May 28, 2015 (the “Compromise
Agreement” and, together with the Waiver Agreement, the “Agreements”), whereby, among other things,
Capstone granted to the Company three separate contingent call option rights to acquire from Capstone, at a call option exercise
price of $0.01 per share, a number of shares of outstanding Company Common Stock owned by Capstone;

 

WHEREAS, the
Company has requested that Capstone waive any fee that might otherwise be due under the Waiver Agreement with respect to Investor;

 

WHEREAS, Capstone
has requested the termination of all of the contingent call option rights under the Compromise Agreement;

 

WHEREAS, Capstone
has agreed to waive its right to any fee with respect to Investor pursuant to the Waiver Agreement; and

 

WHEREAS, the
Company has agreed to terminate all of the contingent call option rights under the Compromise Agreement.

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby expressly acknowledged, the parties agree
as follows:

 

1.                 
Section 1.2 of the Waiver Agreement is hereby deleted in its entirety and replaced with the following:

 

“Accordingly, for good
and valuable consideration, the sufficiency and receipt of which are hereby expressly acknowledged, Capstone shall, and hereby
does, waive the Noncircumvention Provision as to the Investor.”

 

2.                 
Section 2 (inclusive of sub-sections 2.1 through 2.9) of the Waiver Agreement is hereby deleted in its entirety and replaced
with the following:

 

“2. No Waiver Fee.
Capstone is providing the waiver granted to Company herein with respect to the Investor free of charge (except for the consideration
set forth in a certain Amendment to this Agreement dated October 1, 2015), and there shall be no waiver fee, or fee of any kind,
due to Capstone with respect to the waiver granted herein or with respect to any investment at any time by Investor in the equity
securities of the Company, including without limitation, options or convertible securities.”

 

     

     

    

 

3.                 
In addition to and without limitation of the group of persons and entities currently identified and defined as “Investor”
in Schedule A to the Waiver Agreement, the term Investor as used therein shall, and does hereby, also expressly include Golisano
Holdings, LLC, a New York limited liability company.

 

4.                 
Section 5 of the Compromise Agreement is hereby deleted in its entirety and replaced with the following: “[Reserved.]”

 

 5.                 
Exhibit B of and to the Compromise Agreement is hereby deleted in its entirety.

 

6.                 
Each party hereto agrees to execute and perform such other documents and acts as are reasonably required in order to facilitate
the terms of this Amendment, and the intent thereof, and to cooperate in good faith in order to effectuate the provisions of this
Amendment.

 

7.                 
Each party represents and warrants to the other party that its execution and delivery of this Amendment have been duly authorized
by its Board of Directors and do not violate any law or any agreement between it and any third party. Each individual signing this
Amendment on behalf of a party represents and warrants in his individual capacity to the other party that his execution and delivery
of this Amendment on behalf of such first party has been duly authorized by such first party’s Board of Directors.

 

8.                 
Except as expressly modified by this Amendment, all terms and conditions of the respective Agreements shall remain in full
force and effect.

 

9.                 
This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall
be deemed to be one and the same instrument. A signed, including electronically signed, copy of this Amendment delivered by facsimile,
email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed
copy of this Amendment.

 

IN WITNESS WHEREOF,
each of the undersigned has executed this Amendment No. 1 to Agreement for Limited Waiver of Non-Circumvention Provision and to
Compromise Agreement and Release as of the day and year first written above.

 

 

	COMPANY	 	CAPSTONE
	 	 	 
	Twinlab Consolidated Holdings, Inc.	 	Capstone Financial Group, Inc.
	 	 	 
	By: 	/s/ Thomas Tolworthy	 	By:  	/s/ Darin Pastor
	 	Thomas Tolworthy	 	 	Darin Pastor
	 	Chief Executive Officer	 	 	Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]